FENC
FENNEC PHARMACEUTICALS INC.
Key Financials
Gross Profit
$20.0M
↑ 1279.8%
Operating Income
$-6282000
↓ 344.6%
Net Income
$-9741000
↓ 2134.2%
Revenue
$44.6M
↓ 6.1%
Total Assets
$70.6M
↑ 57.0%
EPS (Diluted)
$-0.34
↓ 1600.0%
Cash & Equivalents
$36.8M
↑ 38.1%
Total Liabilities
$35.1M
↓ 31.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/7/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| 144 | 4/1/2026 | View on SEC |
| 10-K | 3/27/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FENC |
| Company Name | FENNEC PHARMACEUTICALS INC. |
| CIK | 1211583 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | (919) 636-4530 |